Orchid Pharma share news, announcements and annual reports
NSE: ORCHPHARMABSE: 524372Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹893.40.
30 Oct: open ₹893.45, high ₹893.45, low ₹830.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,009 Cr919th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 88,12456.8% delivered
Orchid Pharma share news and announcements
856 announcements, routine notices left out, newest first. Page 4 of 18.
Feb 2024
5 Feb · Analysts
Jan 2024
Dec 2023
15 Dec · Rating
6 Dec · Business
Nov 2023
30 Nov · Rating
28 Nov · Meeting
27 Nov · Meeting
4 Nov · Results
2 Nov · Analysts
Oct 2023
28 Oct · Board meeting
28 Oct · Meeting
20 Oct · Management
Sep 2023
27 Sep · Updates
12 Sep · Business
Aug 2023
14 Aug · Business
10 Aug · Results
9 Aug · Meeting
Jul 2023
18 Jul · Meeting
13 Jul · Corporate action
13 Jul · Meeting
Jun 2023
27 Jun · Board meeting
27 Jun · Board meeting
27 Jun · Board meeting
22 Jun · Board meeting
May 2023
10 May · Results
8 May · Analysts
3 May · Board meeting
Mar 2023
3 Mar · Updates
Feb 2023
14 Feb · Analysts
9 Feb · Results
9 Feb · Rating